What MMP-9 measures, and why the specimen matters
A person can receive a result that looks high against an old 332 ng/mL target but sits inside the current laboratory interval. The number can also change with the specimen and collection method: serum is usually higher than plasma because cells release MMP-9 while the blood clots. Before reacting to the value, match the report to the current assay, interval, specimen, handling, and reason for testing.
Biology
An enzyme used in repair and inflammation
MMP-9 helps break down and reshape extracellular material. Neutrophils and other cells can release it during infection, injury, inflammation, and tissue remodeling.
Specimen
Clotting can raise serum MMP-9
Blood cells release MMP-9 while serum forms. Plasma research values are usually lower, and the collection tube can change the result again.
Range
The old 332 ceiling is not current
The current referred serum ELISA uses an upper limit near 984 ng/mL. Keep the dated laboratory interval instead of an older CIRS target.
Use
This is a specialist research-context test
It may contribute to selected inflammation or research questions. It is not a routine standalone test for brain fog, mold exposure, CIRS, ME/CFS, or Long COVID.
Serum concentration, plasma concentration, enzyme activity, tissue staining, and gene expression may all be called MMP-9. They can't share one cutoff or one trend line.
Save this test
Save the specimen with the number
My Fog keeps the current interval, frozen-serum details, and clinical context beside the value. That way, nobody mistakes a comparison with a plasma study or an outdated CIRS cutoff for a change over time.
Repeat only when the same method and handling answer a named clinical question. Do not repeat until the number reaches a preferred internet target.
What can change how this result is read?
The current commercial listings give one range, with no reliable age or sex ranges. Research shows age, specimen, neutrophils, smoking, vascular risk, pregnancy, and disease context can affect MMP-9. So the printed interval is only a starting point.
Infants and children
The current US listing has no separate range for children, and the main collection studies used adults. A pediatric clinician should first check growth, sleep, nutrition, infection, medicines, breathing, vision, hearing, school function, and the child's symptoms. Do not use an adult internet target.
Teenagers and adults
Keep recent infection, fever, injury, surgery, hard exercise, smoking, alcohol, blood pressure, weight, medicines, and CBC neutrophils beside the result. A study of 345 adults aged 45 to 69 linked plasma MMP-9 to smoking, systolic blood pressure, alcohol, CRP, and total cardiovascular risk load. That study found a link, not a treatment target.
Women, pregnancy, and postpartum
Researchers study MMP-9 in pregnancy, but there is no pregnancy range for this test. Tell the obstetric clinician about the result. Get direct obstetric advice for a severe headache, vision change, upper-belly pain, trouble breathing, or sudden swelling during pregnancy or within six weeks after birth.
Men
One specimen study included only 61-year-old men, while other population studies included both sexes. Neither supplies a male CIRS target. Use the performing laboratory's interval and keep smoking, vascular risk, infection, injury, exercise, medicines, and neutrophil count in view.
Older adults
In one plasma study of 77 adults aged 20 to 90 without known cardiovascular disease, MMP-9 decreased across age groups while other MMPs and inhibitors increased. Cancer, lung disease, vascular disease, autoimmune illness, infection, injury, medicines, and blood-cell counts also become more relevant with age. Do not turn one specialist marker into an aging or cognitive diagnosis.
How to get a usable frozen-serum result
Before the appointment, photograph the order and ask which laboratory will perform the test. Confirm that it is MMP-9 protein by ELISA, not MMP9 genetic testing, tissue staining, enzyme activity, a research multiplex panel, or another matrix metalloproteinase.
Ask the collection site to read the performing laboratory's instructions. Labcorp's current assay uses serum from a gel-barrier tube, transferred into a plastic transport tube before freezing. ARUP requires a serum separator tube, transfer to its transport tube, immediate freezing, and critical frozen transport.
The current Labcorp and ARUP listings do not require fasting or avoiding exercise. Follow the written order and keep taking medicines unless told otherwise. Record recent infection, fever, injury, surgery, hard exercise, smoking, pregnancy, medicines, steroid use, and the reason for testing.
If this is a repeat, use the same performing laboratory, specimen, method, and handling when possible. Bring the earlier full report. Serum and plasma results don't belong on one trend line.
Confirm the exact MMP-9 test
Match the test name, specimen, method, unit, performing laboratory, and report date. Protein concentration, enzyme activity, tissue expression, and gene variants answer different questions.
Use the required serum tube
For the current US referral assay, collect a serum separator or gel-barrier tube. Do not substitute EDTA or heparin plasma unless the performing laboratory ordered and validated that specimen.
Transfer and freeze the serum
Move the separated serum into the specified plastic transport tube and freeze it. ARUP calls frozen transport critical and lists ambient and refrigerated storage as unacceptable. Labcorp lists only 30 minutes of room-temperature stability.
Keep the interval with the number
Save the value, ng/mL unit, interval, assay, specimen, and performing laboratory together. Do not replace the current report interval with 85 to 332 ng/mL from an older CIRS source.
Ask what decision it changes
Ask which condition the clinician is checking. Also ask which usual tests and exam findings matter, and what each possible MMP-9 result would change.
How to understand an MMP-9 result
Start with the report date, performing laboratory, specimen, method, unit, current interval, and frozen handling. Then interpret the value beside the reason for testing, symptoms, examination, and ordinary clinical tests.
Inside this assay's interval
Inside the current report interval
The result is inside that laboratory's interval for that specimen and assay. It does not rule out a damp building, respiratory disease, infection, ME/CFS, Long COVID, vascular disease, or another cause of brain fog.
Near a limit or changed method
Near a limit or different from an older report
First compare the specimen, collection tube, assay, laboratory, unit, handling, and interval. A small change may be a method change rather than a meaningful change in the body.
Outside this assay's interval
Outside the current report interval
Confirm that the correct interval and specimen were used. A true high value remains nonspecific and needs the reason for testing, symptoms, examination, CBC with differential, ordinary inflammatory markers, and condition-specific assessment.
An old cutoff and a different specimen can create a false alarm
The current commercial ceiling near 984 ng/mL is about three times the old 332 ng/mL target. Serum is also higher than plasma because cells release MMP-9 during clotting. Neither difference proves that inflammation worsened or that mold caused the result.
See research details
These figures answer different questions. Keep each number with its assay, specimen, population, and study design.
Use the interval printed on the dated report. The older 85 to 332 ng/mL figure isn't a universal target, and it doesn't apply to the current assay.
Do not compare a serum result with a plasma research value or call the difference disease progression. Keep the specimen and collection tube beside every result.
A repeat is only comparable when the laboratory, specimen, tube, collection method, and processing stay as close as possible.
This small exploratory comparison doesn't prove the commercial assay works for diagnosis. It doesn't set a cutoff for brain fog, explain one person's symptoms, or show that lowering MMP-9 improves ME/CFS.
These numbers do not establish population sensitivity, specificity, a universal 332 ng/mL cutoff, or proof that one MMP-9 result identifies a building exposure. The study used a selected group, not a general diagnostic population.
Use water damage, visible dampness, odor, building inspection, and supported respiratory or allergy assessment for the building question. A blood enzyme cannot name a building, species, dose, or safe return date.
What to do after an MMP-9 result
There is no validated food, supplement, or home protocol for driving a commercial MMP-9 result to a preferred number. Useful action means checking the result, addressing established health risks, and investigating the symptom or building question directly.
Audit the full report
Save the date, value, ng/mL unit, interval, specimen, assay, performing laboratory, tube, transfer, freezing, and comments. If someone used 332 ng/mL, ask whether that target applies to the assay and date on your report.
Work on established risks, not the marker
If you smoke or use tobacco, getting help to stop is useful regardless of MMP-9. CDC says quitting reduces markers of inflammation and cardiovascular risk. Regular movement, sleep, blood-pressure care, and food that supports ordinary cardiovascular health are worthwhile for health, but none is proven to treat a personal MMP-9 result.
Investigate the symptom that led to testing
Bring the timing of thinking problems, fatigue, fever, pain, breathing symptoms, allergy, infection, sleep, medicines, diet, periods or pregnancy, and neurologic changes. Ask whether CBC with differential, CRP, ESR, metabolic, thyroid, iron, B12, glucose, sleep, medication, respiratory, or neurologic assessment fits the symptoms better.
Treat dampness as a building problem
If you see or smell dampness or mold, stop the water source and dry wet materials. Take photos of damage. Get qualified help if the source is hidden or the area is large. An MMP-9 result cannot show where mold is.
Do not start a binder, antifungal, fish-oil dose, supplement, steroid, immune medicine, prescription treatment, restrictive diet, or major remediation because of MMP-9 alone. Chest pain, severe breathlessness, coughing blood, fainting, sudden confusion, facial droop, speech trouble, one-sided weakness, or a new severe headache needs urgent assessment.
What to save for a clinician visit
Keep these together
- Full dated report, performing laboratory, method, specimen, value, ng/mL unit, and printed interval
- Collection tube, transfer tube, freeze timing, transport condition, and any handling or rejection comments
- CBC and neutrophil count, recent infection, fever, injury, surgery, hard exercise, smoking, pregnancy, medicines, and steroid use
- Reason for testing, symptoms and timing, building evidence, ordinary inflammatory tests, and clinician interpretation
- What decision the test changed and the exact method and conditions required for any comparison
Question for the visit
“Is this the current frozen-serum assay, could the specimen or collection method explain the value, what non-mold causes matter, and what decision would a repeat change?”
Sources for MMP-9 (Matrix Metalloproteinase-9)
Current frozen-serum ELISA, 0 to 983 ng/mL interval, handling, stability, research-use limitation, and nonspecific disease contexts.
Current SST collection, immediate freezing, critical frozen transport, stability, referral status, and by-report interval.
Less than 984 ng/mL example interval, Esoterix performance, and manufacturer research-use limitation.
Serum versus heparin plasma, clot-activator effect, threefold difference, 78 healthy participants, and specimen-dependent diagnostic patterns.
Serum versus plasma, Vacutainer versus syringe, neutrophil association, 473 men, and ten-person sampling substudy.
Exploratory ME/CFS serum study, 18 patients and 18 controls, reported means, female cohort, stored samples, and biomarker limits.
Selected water-damaged-building cohort, baseline MMP-9, time series, small treatment comparison, and limits on general diagnostic claims.
Evidence-based medical diagnostic boundaries for indoor mold exposure.
No health-based indoor mold standards, inspection and odor evidence, moisture correction, and routine testing limits.
Age-related plasma MMP and TIMP findings in 77 adults aged 20 to 90 without known cardiovascular disease.
Plasma MMP-9 associations with smoking, blood pressure, alcohol, CRP, and cardiovascular risk in 345 adults.
First-trimester MMP-9 research in 90 pregnant participants and limits of predictive use.
Pregnancy and postpartum warning symptoms that need direct obstetric care.
Benefits of quitting smoking, including lower inflammatory markers and cardiovascular risk.
General adult activity guidance for health, not treatment of an MMP-9 value.
See each claim's sources
range
The current Labcorp frozen-serum ELISA lists 0 to 983 ng/mL, while ARUP's September 2025 referred example report prints less than 984 ng/mL and the same research-use diagnostic limitation.procedure
The current referral assay requires serum from an SST or gel-barrier tube, transfer to a plastic transport tube, freezing, and frozen transport; ARUP lists ambient and refrigerated storage as unacceptable.limitation
Serum MMP-9 is higher than heparin-plasma MMP-9, and clot-activated serum was about threefold higher than native serum in a study of 78 healthy participants and two cancer groups.limitation
Specimen and sampling method changed MMP-9 values, and serum MMP-9 tracked neutrophils more strongly than plasma in a study of 473 men with a ten-person pre-analytical substudy.interpretation
A 2026 study reported mean serum MMP-9 of 126 ng/mL in 18 female ME/CFS patients and 17 ng/mL in 18 controls, but it did not establish a diagnostic cutoff or treatment response.limitation
The 2006 water-damaged-building study selected 28 clinical cases, 26 completed the time series, 22 had abnormal baseline MMP-9, and 13 entered a seven-versus-six treatment comparison, so it does not establish general diagnostic accuracy.limitation
Serum MMP-9 is not an established diagnostic test for indoor mold exposure, a contaminated building, or CIRS.